title: Does the use of recombinant factor VIIA reduce morbidity or mortality in nonhemophiliac patients?
authors.affiliation: Department of Emergency Medicine, Good Samaritan Hospital Medical Center, West Islip, NY, USA.
authors.forename: Steven
authors.initials: S
authors.lastname: Sattler
authors.forename: Adam
authors.initials: A
authors.lastname: Schwartz
mesh_terms: D015942:Factor VIIa / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D006490:Hemostatics; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa